Clinical & translational oncology

• 

  Año 2025, Vol. 27, Número 9

  • REVIEW ARTICLE

    • Landscape and clinical implications of EGFR exon 20 insertions in non-small cell lung cancer patients

      Mónica Garzón Ibáñez, Roxana Reyes, Miguel Ángel Molina Vila, Ivana Gabriela Sullivan

      • Resumen

      págs. 3559-3569

      

    • Is SBRT the optimal first-line treatment for operable early-stage NSCLC in elderly patients?

      Ana Maria Soto Cambres, Núria Farré Bernadó

      • Resumen

      págs. 3570-3579

      

    • Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

      Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas, M.J. Fernández Aceñero, Ana Fernández Montes, Carlos Gómez Martín, P. Jiménez Fonseca, Maria Carolina Martinez Ciarpaglini, Fernando Rivera Herrero, Mar Iglesias

      • Resumen

      págs. 3580-3594

      

    • Oral microbes and gastrointestinal cancers: new strategies and insights

      Chenlu Huang, Yu Li, Cong He

      • Resumen

      págs. 3595-3606

      

    • HER2-targeted therapy in colorectal cancer: a comprehensive review

      Yeliz Benli, Özge Akbulut Çalışkan, Helin Arıkan

      • Resumen

      págs. 3607-3624

      

    • The therapeutic efficacy and application prospects of tumor-treating fields (TTFields) in resolving malignant tumors of central nervous system

      Wei Han, Liang Chen

      • Resumen

      págs. 3625-3635

      

    • Sex-related differences in the efficacy and toxicity of cancer treatments

      Ana Santaballa Bertrán, José Antonio Marcos Rodríguez, Ana Cardeña Gutiérrez, Virginia Martínez Callejo, Oliver Higuera, Beatriz Bernárdez Ferrán, M. Estela Moreno Martínez, Margarita Majem

      • Resumen

      págs. 3636-3646

      

  • RESEARCH ARTICLE

    • Low versus null HER2 tumour expression in “HER2-negative” breast cancer: long-term outcomes based on phenotypes

      Israel Barco Nebreda, Clarisa González, Marc García Font, Antonio García Fernández, Manel Fraile, Xavier Tarroch Sarasa, Xavier Morlius, M. C. Vidal, S. González, Claudia B. Mitru, Elena Vallejo, Gerard Molina, Marta Torras, Carolina Chabrera Sanz

      • Resumen

      págs. 3647-3654

      

    • Influence of CYP2D6 polymorphisms on tamoxifen side effects in patients with breast cancer

      Isabel Blancas López-Barajas, Marina Linares Rodríguez, Carlos José Rodríguez González, Fernando Rodríguez Serrano

      • Resumen

      págs. 3655-3663

      

    • Treatment patterns and survival outcomes in patients with small-cell lung cancer following failure of first-line platinum-based chemotherapy

      Chi Lu Chiang, Ying Ting Liao, Ruei Lin Sun, Hsu Ching Huang, Chia I Shen, Yen Han Tseng, Yung Hung Luo, Yuh Min Chen

      • Resumen

      págs. 3664-3671

      

    • The effects of psychological intervention on negative emotions, pain, and sleep in patients with advanced colon cancer

      Gang Wang, Shengjie Pan

      • Resumen

      págs. 3672-3678

      

    • Prediction of lymph node metastasis in stage I–III colon cancer patients younger than 40 years

      Wei Hao Zhang, Meng Di Huang, Yan Ling Tu, Kun Zhai Huang, Chao Jun Wang, Zhao Hui Liu, Rui Sheng Ke

      • Resumen

      págs. 3679-3686

      

    • Prognostic value of extracellular vesicles in colorectal cancer: a systematic review and meta-analysis

      Haodong Zhang, Tingting Zhou, Liaoqiong Fang, Bohan Wu

      • Resumen

      págs. 3687-3700

      

    • PSA reduction as predictor of biochemical relapse in low and favourable intermediate prostate cancer treated with radical radiotherapy

      Andrea Gaetano Allegra, Luca Nicosia, Alessandro Molinari, Chiara De Colle, Christian Fierro, Niccolò Giaj Levra, Francesca Giannetti, Claudia Menichelli, Carolina Orsatti, Gabriella Pastore, Edoardo Pastorello, Francesco Ricchetti, Michele Rigo, Andrea Romei, Paola Zuccoli, Alessandro Fanelli, Filippo Alongi

      • Resumen

      págs. 3701-3706

      

    • Enhanced anti-tumor effects of combined electric fields, cabozantinib, and radiation therapy in metastatic renal cell carcinoma

      Jinju Heo, Yunhui Jo, Myonggeun Yoon

      • Resumen

      págs. 3707-3716

      

    • Artificial intelligence in dysphagia assessment: evaluating lingual muscle composition in head and neck cancer

      Laura Ferreira, Barbara Salas Salas, Fiorella Palmas Candia, Raquel Diaz Saavedra, Anais Ramos Ortiz, Pedro C. Lara, Marta Lloret Sáez-Mravo

      • Resumen

      págs. 3717-3731

      

    • Assessing oral and dental health-related quality of life in head and neck cancer patients at 1, 5, and 10 years: a comparison of the EORTC QLQ43, FACT H&N, and the Orthognathic-QLQ questionnaires

      Marc Guedea, Meritxell Sánchez Molins, Alicia Lozano, Montse Ferrer, Angels Pont, Sandra Clotet, Marc Juárez, Isabel Linares, Pablo Araguas, Montse Ventura, Nuno Gustavo d'Oliveira, María Cristina Manzanares Céspedes, Josep Mª Ustrell Torrent, Ferrán Guedea Edo

      • Resumen

      págs. 3732-3744

      

    • In vitro anticancer effect of epigallocatechin gallate nano-emulsion on head and neck cancers

      Zahra Khatib Zadeh, Samaneh Arab, Sohrab Kazemi, Mohadeseh Arabhalvaei, Elham Sadat Afraz, Marjan Bahraminasab

      • Resumen

      págs. 3745-3762

      

    • Assessment of telomerase expression in melanoma and cutaneous squamous cell carcinoma: correlation with clinical parameters

      Tuqa Nasser Alsurhi, Asem Shalaby, Shadia Al-Sinawi, Mohamed Mabruk

      • Resumen

      págs. 3763-3769

      

    • Prognostic utility of the CALLY index in metastatic melanoma: building a nomogram for Patients on Anti-PD-1 therapy

      Caner Acar, Haydar Çağatay Yüksel, Gökhan Şahin, Fatma Pinar Açar, Damla Gunenc, Burçak Karaca

      • Resumen

      págs. 3770-3780

      

    • A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery

      Susana Buendía López, Alba Rubio San Simón, Jen Hao Wu, D. Azorín Cuadrillero, Ana Sanz Miguel, Álvaro Lassaletta Atienza, S. Sirvent Cerdá, Laura Rey Portela, Juan Carlos Abril Martín, Lucas Moreno, Luis Madero López, Javier García Castro, F. J. Bautista Sirvent

      • Resumen

      págs. 3781-3792

      

    • Assessing the accuracy of the GPT-4 model in multidisciplinary tumor board decision prediction

      Efe Cem Erdat, Merih Yalçıner, Mehmet Berk Örüncü, Yüksel Ürün, Filiz Çay Şenler

      • Resumen

      págs. 3793-3802

      

    • Validation of a cancer population derived AKI machine learning algorithm in a general critical care scenario

      Lauren Abigail Scanlon, Catherine O'Hara, Matthew Barker Hewitt, Jorge Barriuso

      • Resumen

      págs. 3803-3810

      

    • Comparison of oncological care in a hospital center before and after the integration of specialized oncology services

      Cristina Quero Blanco, D. Martín García, Francisco Rivas Ruiz, M. García Aranda, M. Redondo

      • Resumen

      págs. 3811-3818

      

  • BRIEF RESEARCH ARTICLE

    • CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists’ perceptions

      F. Moreno, V. Iranzo, Isabel Álvarez, A. Antón Torres, José Ignacio Chacón López Muñiz, Joaquín Gavilá Gregori, Miguel Martín Jiménez, Pedro Sánchez Rovira, P. Gratal, M. J. Fernández González, Rafael López López

      • Resumen

      págs. 3819-3826

      

    • Frequency and predictors of caregiver burden among patients with cancer receiving palliative cancer treatment

      Juan Luis Torres Tenor, Elsa Bernal Hertfelder, Ana Pertejo Fernández, Jorge Luis Ramón Patiño, Andrés Redondo Sánchez, Alberto Alonso Babarro, Eduardo Bruera

      • Resumen

      págs. 3827-3832

      

  • CORRECTION

    • Correction: Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

      Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas, M.J. Fernández Aceñero, Ana Fernández Montes, Carlos Gómez Martín, P. Jiménez Fonseca, Maria Carolina Martinez Ciarpaglini, Fernando Rivera Herrero, Mar Iglesias

      págs. 3833-3835

      

    • Correction: Assessment of telomerase expression in melanoma and cutaneous squamous cell carcinoma: correlation with clinical parameters

      Tuqa Nasser Alsurhi, Asem Shalaby, Shadia Al-Sinawi, Mohamed Mabruk

      págs. 3836-3836